We have an embarrassment of riches today with two visual abstracts for the trial. I am seeing two opposing poles in the visual abstracts, leaning toward more information or leaning toward less information. I think these two visual abstracts demonstrate the differences nicely.
Trial of Tolvaptan in ADPKD, REPRISED: The Visual Abstracts